1. The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity
- Author
-
Eden Koo, Abdelwahab Jalal Eldin, Muhammet Ozer, Amy E. Rothberg, Baris Akinci, Nicole Miller, Rasimcan Meral, Maria C Foss-Freitas, and Elif A. Oral
- Subjects
medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Hyperlipidemias ,030209 endocrinology & metabolism ,Gastroenterology ,Metabolic equivalent ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Diabetes mellitus ,Internal medicine ,Metabolic Equivalent ,Diabetes Mellitus ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Glycemic ,Nutrition and Dietetics ,business.industry ,Leptin ,Hypertriglyceridemia ,medicine.disease ,Familial partial lipodystrophy ,Obesity ,Lipodystrophy, Familial Partial ,Obesity, Morbid ,business - Abstract
OBJECTIVE This study aimed to investigate the shortcoming of BMI as a measurement of adiposity in patients with familial partial lipodystrophy (FPLD). METHODS Two different matching procedures were used to compare 55 FPLD versus control patients with severe obesity (N = 548 patients) to study the relationship between body weight, fat distribution, and metabolic diseases, such as diabetes mellitus, hypertriglyceridemia, and nonalcoholic steatohepatitis. In MATCH1, the patients with FPLD were matched to controls with obesity (OCs) by truncal mass, and in MATCH2, the patients with FPLD were matched to OCs with respect to glucose control. RESULTS With MATCH1, the FPLD group had worse glycemic control (hemoglobin A1c 8.2% ± 1.6% vs. 5.9% ± 0.9%), higher triglycerides (884 ± 1,190 mg/dL vs. 139 ± 79 mg/dL), and lower leptin (20.5 ± 15.8 ng/mL vs. 41.9 ± 29.4 ng/mL, P
- Published
- 2021